Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Auvi-Q
Pharma
Sanofi puts Mylan's EpiPen pricing, rebates in crosshairs
Sanofi argues Mylan blocked competition to its EpiPen competitor Auvi-Q, leveraging price hikes and steep rebates to maintain an epinephrine monopoly.
Fraiser Kansteiner
Jun 2, 2021 11:01am
Trump's pick for $354M manufacturing deal could raise eyebrows
May 21, 2020 12:09pm
Adamis sues rival epinephrine maker Kaléo for cybersquatting
Jul 2, 2019 10:58am
Novartis, Adamis keep swinging at EpiPen with new Symjepi dose
Sep 28, 2018 11:06am
With EpiPen competitors bearing down, can Mylan maintain its lead?
Sep 18, 2018 12:08pm
Kaléo strikes Walgreens pact to stock Auvi-Q nationwide
Sep 6, 2018 12:05pm